Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK

por Campbell, H E, Gray, A M, Harris, A L, Briggs, A H, Taylor, M A
Publicado 2010

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

por Mitra, A, Conway, C, Walker, C, Cook, M, Powell, B, Lobo, S, Chan, M, Kissin, M, Layer, G, Smallwood, J, Ottensmeier, C, Stanley, P, Peach, H, Chong, H, Elliott, F, Iles, M M, Nsengimana, J, Barrett, J H, Bishop, D T, Newton-Bishop, J A
Publicado 2010

Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locor...

por van Herpen, C M L, Mauer, M E, Mesia, R, Degardin, M, Jelic, S, Coens, C, Betka, J, Bernier, J, Remenar, E, Stewart, J S, Preiss, J H, van den Weyngaert, D, Bottomley, A, Vermorken, J B
Publicado 2010

Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α

por Kornmann, M, Staib, L, Wiegel, T, Kreuser, E-D, Kron, M, Baumann, W, Henne-Bruns, D, Link, K-H
Publicado 2010

A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer

por Rossi, J-F, Négrier, S, James, N D, Kocak, I, Hawkins, R, Davis, H, Prabhakar, U, Qin, X, Mulders, P, Berns, B
Publicado 2010

Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer

por Godinho, M F E, Sieuwerts, A M, Look, M P, Meijer, D, Foekens, J A, Dorssers, L C J, van Agthoven, T
Publicado 2010

Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value

por Michlmayr, A, Bachleitner-Hofmann, T, Baumann, S, Marchetti-Deschmann, M, Rech-Weichselbraun, I, Burghuber, C, Pluschnig, U, Bartsch, R, Graf, A, Greil, R, Allmaier, G, Steger, G, Gnant, M, Bergmann, M, Oehler, R
Publicado 2010

A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer

por López, R, Salgado, M, Reboredo, M, Grande, C, Méndez, J C, Jorge, M, Romero, C, Quintero, G, de la Cámara, J, Candamio, S
Publicado 2010

Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699

por Daniel, R A, Rozanska, A L, Mulligan, E A, Drew, Y, Thomas, H D, Castelbuono, D J, Hostomsky, Z, Plummer, E R, Tweddle, D A, Boddy, A V, Clifford, S C, Curtin, N J
Publicado 2010

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

por Tomimaru, Y, Eguchi, H, Nagano, H, Wada, H, Tomokuni, A, Kobayashi, S, Marubashi, S, Takeda, Y, Tanemura, M, Umeshita, K, Doki, Y, Mori, M
Publicado 2010

The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer

por Richards, C H, Leitch, E F, Horgan, P G, Anderson, J H, McKee, R F, McMillan, D C
Publicado 2010

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

por Bernhard, J, Dietrich, D, Glimelius, B, Hess, V, Bodoky, G, Scheithauer, W, Herrmann, R
Publicado 2010

Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer

por Guiu, S, Gauthier, M, Coudert, B, Bonnetain, F, Favier, L, Ladoire, S, Tixier, H, Guiu, B, Penault-Llorca, F, Ettore, F, Fumoleau, P, Arnould, L
Publicado 2010

Oral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition

por Tsilidis, K K, Allen, N E, Key, T J, Bakken, K, Lund, E, Berrino, F, Fournier, A, Olsen, A, Tjønneland, A, Overvad, K, Boutron-Ruault, M-C, Clavel-Chapelon, F, Byrnes, G, Chajes, V, Rinaldi, S, Chang-Claude, J, Kaaks, R, Bergmann, M, Boeing, H, Koumantaki, Y, Stasinopoulou, G, Trichopoulou, A, Palli, D, Tagliabue, G, Panico, S, Tumino, R, Vineis, P, Bueno-de-Mesquita, H B, van Duijnhoven, F J B, van Gils, C H, Peeters, P H M, Rodríguez, L, González, C A, Sánchez, M-J, Chirlaque, M-D, Barricarte, A, Dorronsoro, M, Borgquist, S, Manjer, J, van Guelpen, B, Hallmans, G, Rodwell, S A, Khaw, K-T, Norat, T, Romaguera, D, Riboli, E
Publicado 2010

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature

por Knauer, M, Cardoso, F, Wesseling, J, Bedard, P L, Linn, S C, Rutgers, E J T, van 't Veer, L J
Publicado 2010

Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system

por Chow, I H-I, Tang, C-H, You, S-L, Liao, C-H, Chu, T-Y, Chen, C-J, Chen, C-A, Pwu, R-F
Publicado 2010

Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival

por Rotunno, M, Zhao, Y, Bergen, A W, Koshiol, J, Burdette, L, Rubagotti, M, Linnoila, R I, Marincola, F M, Bertazzi, P A, Pesatori, A C, Caporaso, N E, McShane, L M, Wang, E, Landi, M T
Publicado 2010

An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer

por Querzoli, P, Coradini, D, Pedriali, M, Boracchi, P, Ambrogi, F, Raimondi, E, La Sorda, R, Lattanzio, R, Rinaldi, R, Lunardi, M, Frasson, C, Modesti, F, Ferretti, S, Piantelli, M, Iacobelli, S, Biganzoli, E, Nenci, I, Alberti, S
Publicado 2010

Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer reg...

por Coleman, MP, Forman, D, Bryant, H, Butler, J, Rachet, B, Maringe, C, Nur, U, Tracey, E, Coory, M, Hatcher, J, McGahan, CE, Turner, D, Marrett, L, Gjerstorff, ML, Johannesen, TB, Adolfsson, J, Lambe, M, Lawrence, G, Meechan, D, Morris, EJ, Middleton, R, Steward, J, Richards, MA
Publicado 2011

The HPV16 E6 binding protein Tip-1 interacts with ARHGEF16, which activates Cdc42

por Oliver, A W, He, X, Borthwick, K, Donne, A J, Hampson, L, Hampson, I N
Publicado 2011